SG11202101085PA - Optically active azabicyclic derivative - Google Patents

Optically active azabicyclic derivative

Info

Publication number
SG11202101085PA
SG11202101085PA SG11202101085PA SG11202101085PA SG11202101085PA SG 11202101085P A SG11202101085P A SG 11202101085PA SG 11202101085P A SG11202101085P A SG 11202101085PA SG 11202101085P A SG11202101085P A SG 11202101085PA SG 11202101085P A SG11202101085P A SG 11202101085PA
Authority
SG
Singapore
Prior art keywords
optically active
azabicyclic derivative
derivative
active azabicyclic
optically
Prior art date
Application number
SG11202101085PA
Other languages
English (en)
Inventor
Seiji Kamioka
Hitoshi Ban
Naoaki Shimada
Wataru Hirose
Akihiko Arakawa
Kazuto Yamazaki
Kenjiro Hira
Original Assignee
Sumitomo Dainippon Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sumitomo Dainippon Pharma Co Ltd filed Critical Sumitomo Dainippon Pharma Co Ltd
Publication of SG11202101085PA publication Critical patent/SG11202101085PA/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10Spiro-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/10Spiro-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D519/00Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Indole Compounds (AREA)
SG11202101085PA 2018-08-27 2019-08-26 Optically active azabicyclic derivative SG11202101085PA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2018158315 2018-08-27
PCT/JP2019/033234 WO2020045334A1 (ja) 2018-08-27 2019-08-26 光学活性なアザビシクロ環誘導体

Publications (1)

Publication Number Publication Date
SG11202101085PA true SG11202101085PA (en) 2021-03-30

Family

ID=69644540

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202101085PA SG11202101085PA (en) 2018-08-27 2019-08-26 Optically active azabicyclic derivative

Country Status (14)

Country Link
US (3) US11369605B2 (ja)
EP (1) EP3845533A4 (ja)
JP (3) JP6671574B1 (ja)
KR (1) KR20210049136A (ja)
CN (1) CN112585140B (ja)
AU (1) AU2019327006B2 (ja)
BR (1) BR112021002090A8 (ja)
CA (1) CA3107743A1 (ja)
EA (1) EA202190623A1 (ja)
MX (1) MX2021002424A (ja)
PH (1) PH12021550229A1 (ja)
SG (1) SG11202101085PA (ja)
TW (1) TWI815954B (ja)
WO (1) WO2020045334A1 (ja)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3835304A4 (en) * 2018-08-08 2022-06-08 Sumitomo Dainippon Pharma Co., Ltd. OPTICALLY ACTIVE BRIDGED PIPERIDINE DERIVATIVE
EA202190623A1 (ru) * 2018-08-27 2021-05-21 Сумитомо Дайниппон Фарма Ко., Лтд. Оптически активное азабициклическое производное
WO2021060453A1 (ja) * 2019-09-27 2021-04-01 大日本住友製薬株式会社 架橋型光学活性2級アミン誘導体
JP7454520B2 (ja) 2020-02-26 2024-03-22 住友ファーマ株式会社 光学活性なアザビシクロ環誘導体からなる医薬
WO2022130270A1 (en) 2020-12-17 2022-06-23 Astrazeneca Ab N-(2-(4-cyanothiazolidin-3-yl)-2-oxoethyl)- quinoline-4-carboxamides
WO2022237626A1 (en) 2021-05-08 2022-11-17 Janssen Pharmaceutica Nv Substituted spiro derivatives
EP4334320A1 (en) 2021-05-08 2024-03-13 JANSSEN Pharmaceutica NV Substituted spiro derivatives
EP4271676A1 (en) * 2021-12-03 2023-11-08 Bionova Pharmaceuticals (Shanghai) Limited Carbonyl substituted diazaspiro compounds and its use
WO2024110649A1 (en) 2022-11-24 2024-05-30 Oryzon Genomics, S.A. Combinations of lsd1 inhibitors and menin inhibitors for treating cancer

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6583148B1 (en) 1999-04-08 2003-06-24 Krenitsky Pharmaceuticals, Inc. Neurotrophic substituted pyrimidines
AR039208A1 (es) 2002-04-03 2005-02-09 Syngenta Participations Ag Compuestos de fenil- y piridilalquinos, composicion herbicida que los contiene, procedimiento de preparacion de aquellos y procedimiento para combatir el crecimiento de plantas indeseadas
TW200528440A (en) 2003-10-31 2005-09-01 Fujisawa Pharmaceutical Co 2-cyanopyrrolidinecarboxamide compound
CL2008000197A1 (es) 2007-01-26 2008-08-01 Smithkline Beecham Corp Compuestos derivados de 2,4-diamino pirimidina, inhibidores de antranilamida de cinasa aurora; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar cancer.
US20090281114A1 (en) 2008-05-08 2009-11-12 Fabre-Kramer Pharmaceuticals, Inc. Indolylalkyl derivatives of pyrimidinylpiperazine and metabolites thereof for treatment of anxiety, depression, and sexual dysfunction
SG11201609336PA (en) 2014-05-13 2016-12-29 Sloan Kettering Inst Cancer Hsp70 modulators and methods for making and using the same
KR20180103053A (ko) 2015-12-22 2018-09-18 비타이 파마슈티컬즈, 인코포레이티드 메닌-mll 상호작용의 억제제
CN109743875B (zh) * 2016-06-10 2022-04-29 生命医药有限责任公司 Menin-mll相互作用的抑制剂
EP3512858B1 (en) 2016-09-14 2023-11-08 Janssen Pharmaceutica NV Fused bicyclic inhibitors of menin-mll interaction
WO2018050686A1 (en) * 2016-09-14 2018-03-22 Janssen Pharmaceutica Nv Spiro bicyclic inhibitors of menin-mll interaction
BR112019005030A2 (pt) * 2016-09-16 2019-06-18 Vitae Pharmaceuticals Inc inibidores da interação de menina-llm
EP3562823B1 (en) * 2016-12-28 2023-02-08 Promega Corporation Functionalized nanoluc inhibitors
CN112105621B (zh) * 2018-03-30 2024-02-20 住友制药株式会社 光学活性桥型环状仲胺衍生物
US10815241B2 (en) * 2018-08-27 2020-10-27 Sumitomo Dainippon Pharma Co., Ltd. Optically active azabicyclo ring derivative
EA202190623A1 (ru) * 2018-08-27 2021-05-21 Сумитомо Дайниппон Фарма Ко., Лтд. Оптически активное азабициклическое производное

Also Published As

Publication number Publication date
US11911381B2 (en) 2024-02-27
US20220288072A1 (en) 2022-09-15
AU2019327006A1 (en) 2021-03-04
CN112585140B (zh) 2023-07-04
PH12021550229A1 (en) 2021-10-11
AU2019327006B2 (en) 2024-02-15
US20240148727A1 (en) 2024-05-09
CA3107743A1 (en) 2020-03-05
US11369605B2 (en) 2022-06-28
WO2020045334A1 (ja) 2020-03-05
JPWO2020045334A1 (ja) 2020-09-03
EP3845533A4 (en) 2022-04-27
TW202024082A (zh) 2020-07-01
TWI815954B (zh) 2023-09-21
CN112585140A (zh) 2021-03-30
JP2023134729A (ja) 2023-09-27
BR112021002090A2 (pt) 2021-05-04
KR20210049136A (ko) 2021-05-04
BR112021002090A8 (pt) 2022-12-06
JP2020105191A (ja) 2020-07-09
JP6671574B1 (ja) 2020-03-25
EP3845533A1 (en) 2021-07-07
MX2021002424A (es) 2021-04-28
JP7317749B2 (ja) 2023-07-31
US20210338668A1 (en) 2021-11-04
EA202190623A1 (ru) 2021-05-21

Similar Documents

Publication Publication Date Title
SG11202101085PA (en) Optically active azabicyclic derivative
EP3612249A4 (en) E-CONNECTED AUTOMATIC INJECTORS
AU201817730S (en) Sunglasses
HUE055412T2 (hu) Vegyületek optikailag aktív eszközökhöz
HUE052305T2 (hu) Hidrofil vegyületek optikailag aktív eszközökhöz
GB2577682B (en) Auto-injector
SG10201909988YA (en) Photodetector
CA188602S (en) Optical structure
GB2589548B (en) Auto-Injector
CA188604S (en) Optical structure
EP3660391A4 (en) OPTICAL UNIT
EP3759266A4 (en) NANOMATERIAL COATED FIBERS
GB201616725D0 (en) Optical stimulation arrangement
EP3626534A4 (en) OPTICAL UNIT
EP3583277A4 (en) POOL CLEANING DEVICE
EP3548950A4 (en) FIBER RIBBONIZER
GB2591977B (en) Auto-Injector
CA204449S (en) Auto-injector
EP3784637A4 (en) INORGANIC FIBER
GB201815847D0 (en) Photodetector
EP3633264A4 (en) OPTICAL UNIT
PL3767166T3 (pl) Układ optyczny
EP3463702A4 (en) FUEL CLEANING SYSTEM
CA194569S (en) Autoinjector
EP3620403C0 (de) Aktivreiniger